Skip to content

To Investigate the Efficacy of an Occluding Dentifrice in Dentinal Hypersensitivity (DH)

A Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02923895
Enrollment
197
Registered
2016-10-05
Start date
2016-10-11
Completion date
2016-12-16
Last updated
2018-10-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dentin Sensitivity

Brief summary

This single centre study will be used to investigate the efficacy of an experimental stannous fluoride containing dentifrice in relieving dentinal hypersensitivity (DH) after short term use compared with a standard fluoride dentifrice.

Detailed description

This will be a single centre, three day, randomised, examiner blind, two treatment arm, parallel design, stratified (by maximum baseline Schiff sensitivity score of the two selected test teeth), controlled study, in participants with at least two sensitive teeth that meet all the criteria at the screening and baseline (pre-treatment) visits. DH will be assessed at baseline (pre-treatment), post-treatment and after 3 days twice daily use.

Interventions

OTHERStannous fluoride

0.454% weight by weight (w/w) stannous fluoride containing 1100 parts per million (ppm) fluoride

0.76% w/w sodium monofluorophosphate containing 1000 ppm fluoride

Sponsors

GlaxoSmithKline
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Demonstrates understanding of the study and willingness to participate as evidenced by voluntary written informed consent and has received a signed and dated copy of the informed consent form. * Aged 18-65 years. * Good general and mental health with, in the opinion of the investigator or medically qualified designee: No clinically significant and relevant abnormalities of medical history or oral examination and absence of any condition that would impact on the participants safety or wellbeing or affect the individual's ability to understand and follow study procedures and requirements. * Understands and is willing, able and likely to comply with all study procedures and restrictions. * At Visit 1 (Screening): Self-reported history of dentinal hypersensitivity (DH) lasting more than six months but not more than 10 years; Minimum of 20 natural teeth; Minimum of 2 accessible non-adjacent teeth (incisors, canines, pre-molars), preferably in different quadrants, that meet all of the following criteria: Signs of facial/cervical gingival recession and/or signs of erosion or abrasion (EAR), tooth with MGI score =0 adjacent to the test area (exposed dentine) only and a clinical mobility of ≤1, tooth with signs of sensitivity measured by qualifying evaporative air assessment (Y/N response) * At Visit 2, Baseline (Pre-treatment): Minimum of two, non-adjacent accessible teeth (incisors, canines, pre-molars), that meet all of the following criteria: Tooth with signs of sensitivity, measured by qualifying tactile stimulus (Yeaple ≤ 20g) and evaporative air assessment (Schiff sensitivity score ≥ 2)

Exclusion criteria

* A woman who is known to be pregnant or who are intending to become pregnant over the duration of the study. * A woman who is breast-feeding. * Known or suspected intolerance or hypersensitivity to the study materials (or closely related compounds) or any of their stated ingredients. * Participation in another clinical study (including cosmetic studies) or receipt of an investigational drug within 30 days of the screening visit, previous participation in this study and any participant who was randomised for inclusion in study 205710 * Recent history (within the last year) of alcohol or other substance abuse. * An employee of the sponsor or the study site or members of their immediate family. * Presence of chronic debilitating disease which, in the opinion of the investigator, could affect study outcomes and any condition which, in the opinion of the investigator, causes xerostomia. * Dental prophylaxis within 4 weeks of Screening, tongue or lip piercing, desensitizing treatment within 8 weeks of Screening (professional sensitivity treatments and non-dentifrice sensitivity treatments), Gross periodontal disease, treatment of periodontal disease (including surgery) within 12 months of Screening, scaling or root planning within 3 months of screening and vital teeth bleaching within 8 weeks of Screening. * Tooth with evidence of current or recent caries, or reported treatment of decay within 12 months of Screening, tooth with exposed dentine but with deep, defective or facial restorations, teeth used as abutments for fixed or removable partial dentures, dental implants, teeth with full crowns or veneers, orthodontic bands or cracked enamel. Sensitive teeth with contributing aetiologies other than erosion, abrasion or recession of exposed dentine and sensitive tooth not expected to respond to treatment with an over-the-counter dentifrice in the opinion of the investigator. * Use of an oral care product indicated for the relief of dentine hypersensitivity within 8 weeks of screening (participants will be required to bring their current oral care products to the site in order to verify the absence of known anti-sensitivity ingredients). * Daily doses of medication/treatments which, in the opinion of the investigator, could interfere with the perception of pain. Examples of such medications include analgesics, anticonvulsants, antihistamines that cause marked or moderate sedation, sedatives, tranquilisers, anti-depressants, mood-altering andanti-inflammatory drugs, currently taking antibiotics or has taken antibiotics within 2 weeks of Baseline and daily dose of a medication which, in the opinion of the investigator, is causing xerostomia. * Any participant who, in the judgment of the investigator, should not participate in the study.

Design outcomes

Primary

MeasureTime frameDescription
Change From Baseline in Schiff Sensitivity Score on Day 3Baseline and Day 3The examiner assessed the participant's response to an evaporative air stimulus for each of the two test tooth using the Schiff Sensitivity Scale which was scored as follows: 0 Participant does not respond to air stimulation, 1 Participant responds to air stimulus but does not request discontinuation of stimulus, 2 Participant responds to air stimulus and requests discontinuation or moves from stimulus, 3 Participant responds to stimulus, considers stimulus to be painful and requests discontinuation of the stimulus. The Schiff sensitivity score was calculated as the average of individual test teeth score. Change from baseline in Schiff sensitivity was calculated as participant level mean change from baseline of the 2 test teeth. A reduction in Schiff Sensitivity score was indicative of an improvement in sensitivity.

Secondary

MeasureTime frameDescription
Change From Baseline in Tactile Threshold on Day 3Baseline and Day 3Tactile threshold was assessed by examiner using a constant pressure probe (Yeaple probe) which allowed application of a known force to the dentin surface from 10 gram\[g\] to an upper threshold of 80g in increments of 10 g. The tactile threshold is the maximum pressure applied at which participant do not report any pain or discomfort. The tactile threshold for each tooth was determined by asking the participant whether the sensation caused discomfort. The pressure setting at which the participant gave two consecutive 'yes' responses was recorded as the tactile threshold. The higher the tactile threshold, the less sensitive the tooth.
Change From Baseline in Schiff Sensitivity Score After a Single UseBaseline to 60 seconds post first treatmentThe examiner assessed the participant's response to an evaporative air stimulus for each of the two test tooth using the Schiff Sensitivity Scale which was scored as follows: 0 Participant does not respond to air stimulation, 1 Participant responds to air stimulus but does not request discontinuation of stimulus, 2 Participant responds to air stimulus and requests discontinuation or moves from stimulus, 3 Participant responds to stimulus, considers stimulus to be painful and requests discontinuation of the stimulus. The Schiff sensitivity score was calculated as the average of individual test teeth score. Change from baseline in Schiff sensitivity was calculated as participant level mean change from baseline of the 2 test teeth. A reduction in Schiff Sensitivity score was indicative of an improvement in sensitivity.
Change From Baseline in Tactile Threshold After a Single UseBaseline to 60 seconds post first treatmentTactile threshold was assessed by examiner using a constant pressure probe (Yeaple probe) which allowed application of a known force to the dentin surface from 10 g to an upper threshold of 80g in increments of 10 g. The tactile threshold is the maximum pressure applied at which participant do not report any pain or discomfort. The tactile threshold for each tooth was determined by asking the participant whether the sensation caused discomfort. The pressure setting at which the participant gave two consecutive 'yes' responses was recorded as the tactile threshold. The higher the tactile threshold, the less sensitive the tooth.

Countries

Canada

Participant flow

Recruitment details

Participants were recruited at a single clinical site in Canada.

Pre-assignment details

A total of 197 participants were screened and enrolled in the study, out of which 192 participants were randomized to the study treatments. Five participants were not randomized: 1 participant was screening failure, and 4 participants withdrew their consent.

Participants by arm

ArmCount
Test Dentifrice
Participants were instructed to dose a dry toothbrush with a full strip of toothpaste. Participants then first brushed each of the qualifying test teeth for 30 seconds each followed by the whole mouth thoroughly for at least 1 timed minute twice daily.
97
Control Dentifrice
Participants were instructed to dose a dry toothbrush with a full strip of toothpaste. Participants brushed the whole mouth thoroughly for at least 1 minute twice daily.
95
Total192

Baseline characteristics

CharacteristicControl DentifriceTotalTest Dentifrice
Age, Continuous46.9 Years
STANDARD_DEVIATION 10.53
46.9 Years
STANDARD_DEVIATION 11.79
46.8 Years
STANDARD_DEVIATION 12.95
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
12 Participants28 Participants16 Participants
Race (NIH/OMB)
Black or African American
31 Participants49 Participants18 Participants
Race (NIH/OMB)
More than one race
1 Participants2 Participants1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
51 Participants113 Participants62 Participants
Sex: Female, Male
Female
72 Participants140 Participants68 Participants
Sex: Female, Male
Male
23 Participants52 Participants29 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 970 / 95
other
Total, other adverse events
1 / 970 / 95
serious
Total, serious adverse events
0 / 970 / 95

Outcome results

Primary

Change From Baseline in Schiff Sensitivity Score on Day 3

The examiner assessed the participant's response to an evaporative air stimulus for each of the two test tooth using the Schiff Sensitivity Scale which was scored as follows: 0 Participant does not respond to air stimulation, 1 Participant responds to air stimulus but does not request discontinuation of stimulus, 2 Participant responds to air stimulus and requests discontinuation or moves from stimulus, 3 Participant responds to stimulus, considers stimulus to be painful and requests discontinuation of the stimulus. The Schiff sensitivity score was calculated as the average of individual test teeth score. Change from baseline in Schiff sensitivity was calculated as participant level mean change from baseline of the 2 test teeth. A reduction in Schiff Sensitivity score was indicative of an improvement in sensitivity.

Time frame: Baseline and Day 3

Population: Analysis for this outcome was performed on Intent-to-treat (ITT) population, defined as all participants who were randomized, received the study treatment at least once and provided at least one post-baseline (post treatment) assessment.

ArmMeasureGroupValue (MEAN)Dispersion
Test DentifriceChange From Baseline in Schiff Sensitivity Score on Day 3At Baseline (Day 0, Pre-treatment)2.44 Score on a scaleStandard Deviation 0.45
Test DentifriceChange From Baseline in Schiff Sensitivity Score on Day 3At Day 31.01 Score on a scaleStandard Deviation 0.956
Test DentifriceChange From Baseline in Schiff Sensitivity Score on Day 3Change from Baseline-1.44 Score on a scaleStandard Deviation 0.811
Control DentifriceChange From Baseline in Schiff Sensitivity Score on Day 3At Baseline (Day 0, Pre-treatment)2.49 Score on a scaleStandard Deviation 0.475
Control DentifriceChange From Baseline in Schiff Sensitivity Score on Day 3At Day 32.37 Score on a scaleStandard Deviation 0.571
Control DentifriceChange From Baseline in Schiff Sensitivity Score on Day 3Change from Baseline-0.13 Score on a scaleStandard Deviation 0.431
p-value: <0.000195% CI: [-1.5, -1.128]ANCOVA
Secondary

Change From Baseline in Schiff Sensitivity Score After a Single Use

The examiner assessed the participant's response to an evaporative air stimulus for each of the two test tooth using the Schiff Sensitivity Scale which was scored as follows: 0 Participant does not respond to air stimulation, 1 Participant responds to air stimulus but does not request discontinuation of stimulus, 2 Participant responds to air stimulus and requests discontinuation or moves from stimulus, 3 Participant responds to stimulus, considers stimulus to be painful and requests discontinuation of the stimulus. The Schiff sensitivity score was calculated as the average of individual test teeth score. Change from baseline in Schiff sensitivity was calculated as participant level mean change from baseline of the 2 test teeth. A reduction in Schiff Sensitivity score was indicative of an improvement in sensitivity.

Time frame: Baseline to 60 seconds post first treatment

Population: Analysis for this outcome was performed on ITT population, defined as all participants who were randomized, received the study treatment at least once and provided at least one post-baseline (post treatment) assessment.

ArmMeasureGroupValue (MEAN)Dispersion
Test DentifriceChange From Baseline in Schiff Sensitivity Score After a Single UseAt Baseline (Day 0, Pre-treatment)2.44 Score on a scaleStandard Deviation 0.45
Test DentifriceChange From Baseline in Schiff Sensitivity Score After a Single UseDay 0 (Post-treatment)1.76 Score on a scaleStandard Deviation 0.781
Test DentifriceChange From Baseline in Schiff Sensitivity Score After a Single UseChange from Baseline-0.68 Score on a scaleStandard Deviation 0.704
Control DentifriceChange From Baseline in Schiff Sensitivity Score After a Single UseAt Baseline (Day 0, Pre-treatment)2.49 Score on a scaleStandard Deviation 0.475
Control DentifriceChange From Baseline in Schiff Sensitivity Score After a Single UseDay 0 (Post-treatment)2.40 Score on a scaleStandard Deviation 0.534
Control DentifriceChange From Baseline in Schiff Sensitivity Score After a Single UseChange from Baseline-0.09 Score on a scaleStandard Deviation 0.401
Secondary

Change From Baseline in Tactile Threshold After a Single Use

Tactile threshold was assessed by examiner using a constant pressure probe (Yeaple probe) which allowed application of a known force to the dentin surface from 10 g to an upper threshold of 80g in increments of 10 g. The tactile threshold is the maximum pressure applied at which participant do not report any pain or discomfort. The tactile threshold for each tooth was determined by asking the participant whether the sensation caused discomfort. The pressure setting at which the participant gave two consecutive 'yes' responses was recorded as the tactile threshold. The higher the tactile threshold, the less sensitive the tooth.

Time frame: Baseline to 60 seconds post first treatment

Population: Analysis for this outcome was performed on ITT population, defined as all participants who were randomized, received the study treatment at least once and provided at least one post-baseline (post treatment) assessment.

ArmMeasureGroupValue (MEAN)Dispersion
Test DentifriceChange From Baseline in Tactile Threshold After a Single UseAt Baseline (Day 0, Pre-treatment)13.40 gStandard Deviation 4.242
Test DentifriceChange From Baseline in Tactile Threshold After a Single UseDay 0, Post-treatment22.47 gStandard Deviation 11.839
Test DentifriceChange From Baseline in Tactile Threshold After a Single UseChange from Baseline9.07 gStandard Deviation 11.418
Control DentifriceChange From Baseline in Tactile Threshold After a Single UseAt Baseline (Day 0, Pre-treatment)13.58 gStandard Deviation 4.416
Control DentifriceChange From Baseline in Tactile Threshold After a Single UseDay 0, Post-treatment14.63 gStandard Deviation 6.069
Control DentifriceChange From Baseline in Tactile Threshold After a Single UseChange from Baseline1.05 gStandard Deviation 5.644
Secondary

Change From Baseline in Tactile Threshold on Day 3

Tactile threshold was assessed by examiner using a constant pressure probe (Yeaple probe) which allowed application of a known force to the dentin surface from 10 gram\[g\] to an upper threshold of 80g in increments of 10 g. The tactile threshold is the maximum pressure applied at which participant do not report any pain or discomfort. The tactile threshold for each tooth was determined by asking the participant whether the sensation caused discomfort. The pressure setting at which the participant gave two consecutive 'yes' responses was recorded as the tactile threshold. The higher the tactile threshold, the less sensitive the tooth.

Time frame: Baseline and Day 3

Population: Analysis for this outcome was performed on ITT population, defined as all participants who were randomized, received the study treatment at least once and provided at least one post-baseline (post treatment) assessment.

ArmMeasureGroupValue (MEAN)Dispersion
Test DentifriceChange From Baseline in Tactile Threshold on Day 3Change from Baseline25.88 gStandard Deviation 19.804
Test DentifriceChange From Baseline in Tactile Threshold on Day 3At Baseline13.40 gStandard Deviation 4.242
Test DentifriceChange From Baseline in Tactile Threshold on Day 3At Day 339.28 gStandard Deviation 20.979
Control DentifriceChange From Baseline in Tactile Threshold on Day 3At Baseline13.58 gStandard Deviation 4.416
Control DentifriceChange From Baseline in Tactile Threshold on Day 3At Day 314.89 gStandard Deviation 6.357
Control DentifriceChange From Baseline in Tactile Threshold on Day 3Change from Baseline1.32 gStandard Deviation 6.111

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026